Mycronic AB (MYCR) AI Stock Analysis

• Market Cap: kr43.90B
• Dividend Yield: 1.23%
• Average Volume (3M): 298.27K
• Price to Earnings (P/E): 25.1
• Beta (1Y): 1.10
• Revenue Growth: 14.48%
• EPS Growth: 0.52%
• Country: SE
• Employees: 2,318
• Sector: Technology
• Sector Strength: 88
• Industry: Industrial - Machinery
• EPS (TTM): 1.11
• Shares Outstanding: 195,833,020
• 10 Day Avg. Volume: 178,059
• 30 Day Avg. Volume: 298,271
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 71 Outperform
• Price Target: kr232.00 ▲(15.48% Upside)

Mycronic AB's strong financial performance is the most significant factor, supported by robust revenue and profit growth, and a solid balance sheet. Technical analysis presents mixed signals, with no clear trend direction. Valuation is moderate, with a reasonable P/E ratio and modest dividend yield. The absence of earnings call data and corporate events does not impact the score.

Mycronic AB Business Overview & Revenue Model

Company Description

Mycronic AB (publ), together with its subsidiaries, develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. The company operates through four segments: Pattern Generators, High Flex, High Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and measuring machines for production of advanced photomasks for manufacturing of screens for TVs, cars, mobile phones, tablets, and computers, as well as the semiconductor components. The High Flex segment develops, manufactures, and markets surface mount technology (SMT) and inspection equipment for flexible printed circuit board (PCBs) assembly. This segment offers MYPro Line, which integrates advanced jet printing and dispensing, pick-and-place, advanced process control solutions, and 3D inspection systems; MYTower material handling systems; and MYSmart dispensing and coating solutions. The High Volume segment develops, manufactures, and markets equipment for dispensing and conformal coating of circuit boards for manufacturers of mobile phones, tablets, computers, and electronics for electric vehicles, as well as automated screen printers. The Global Technologies segment offers die-bonding services for microelectronics and optoelectronic applications; advanced electrical measurement of bare board PCBs and substrates; flying probe test system, an automated electrical measurement system for low to mid quantities and complex boards; and grid test systems for volume bare board verification. It sells its products through agents and distributors. The company serves industrial, aerospace, defense, automotive, energy, medical, and telecom sectors. The company was formerly known as Micronic Mydata AB (publ) and changed its name to Mycronic AB (publ) in June 2014. Mycronic AB (publ) is headquartered in Täby, Sweden.

How the Company Makes Money

Mycronic generates revenue through a combination of product sales, service agreements, and software solutions. The company's primary revenue stream comes from the sale of its high-tech assembly equipment, which is in demand due to the growth of the electronics market. Additionally, Mycronic earns income from maintenance and support services for its machines, ensuring ongoing customer engagement and revenue stability. The company also benefits from software sales that enhance the functionality of its hardware. Strategic partnerships with major players in the electronics and semiconductor industries further bolster its revenue potential, as these collaborations can lead to increased sales and shared technological advancements.

Mycronic AB Financial Statement Overview

Summary

Mycronic AB shows strong financial health with impressive revenue growth, robust profit margins, and a solid balance sheet with low leverage. However, a decline in free cash flow needs attention.

Income Statement

Mycronic AB shows strong revenue growth with a 31.54% increase from 2023 to TTM. The gross profit margin is robust at 54.0% TTM, indicating effective cost management. Net profit margin improved to 24.2%, suggesting enhanced profitability. EBIT and EBITDA margins are solid at 29.8% and 29.9% respectively, indicating efficient operations. Overall, the income statement reflects healthy growth and profitability.

Balance Sheet

The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.03, demonstrating conservative leverage. Return on equity is impressive at 25.7%, indicating efficient use of equity to generate profits. The equity ratio of 67.1% reflects a solid capital structure and financial stability. The balance sheet suggests low financial risk and strong shareholder value.

Cash Flow

Operating cash flow to net income ratio is healthy at 0.76, showing reliable cash generation from operations. However, free cash flow decreased by 17.8% from 2024 to TTM, primarily due to reduced operating cash flow. Despite this, the free cash flow to net income ratio remains strong at 0.74, indicating good cash conversion. Overall, cash flow performance is robust but shows slight pressure from declining free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	8.05B	7.06B	5.71B	5.12B	4.63B	3.88B
Gross Profit	4.38B	3.72B	2.72B	2.29B	2.28B	2.08B
EBITDA	2.54B	2.32B	1.39B	1.11B	1.15B	1.06B
Net Income	1.97B	1.68B	998.00M	741.00M	828.00M	694.00M
Balance Sheet
Total Assets	10.35B	10.41B	8.34B	7.34B	6.14B	5.32B
Cash, Cash Equivalents and Short-Term Investments	1.80B	3.01B	2.14B	1.27B	683.00M	1.30B
Total Debt	197.00M	219.00M	228.00M	270.00M	243.00M	264.00M
Total Liabilities	3.57B	3.84B	3.06B	2.64B	2.14B	1.94B
Stockholders Equity	6.74B	6.53B	5.25B	4.66B	3.96B	3.36B
Cash Flow
Free Cash Flow	995.00M	1.64B	1.41B	712.00M	908.00M	991.00M
Operating Cash Flow	1.42B	1.87B	1.61B	853.00M	998.00M	1.13B
Investing Cash Flow	-1.23B	-500.00M	-195.00M	67.00M	-1.22B	-150.00M
Financing Cash Flow	-848.00M	-552.00M	-447.00M	-382.00M	-437.00M	-288.00M

Mycronic AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 200.90
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MYCR, the sentiment is Positive. The current price of 200.9 is below the 20-day moving average (MA) of 211.06, below the 50-day MA of 213.13, and below the 200-day MA of 208.33, indicating a bullish trend. The MACD of 2.25 indicates Negative momentum. The RSI at 62.26 is Neutral, neither overbought nor oversold. The STOCH value of 94.14 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:MYCR.

Mycronic AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ATCO.B	―	kr771.71B	25.94	26.43%	2.10%	-2.38%	-4.00%
SAND	―	kr362.39B	24.59	16.39%	1.99%	-1.77%	21.13%
ALFA	―	kr188.15B	22.81	20.42%	1.86%	3.54%	20.94%
MYCR	―	kr43.90B	25.10	26.95%	1.23%	14.48%	0.52%
ATCO.A	―	kr752.45B	28.26	26.43%	1.87%	-2.38%	-4.00%
TREL.B	―	kr88.10B	24.83	9.56%	1.89%	2.73%	7.56%
Sector *	―	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%

Mycronic AB Corporate Events

Mycronic AB Sees Strong Order Growth Amidst Sales Decline

Mycronic AB reported a 67% increase in order intake for the third quarter of 2025, driven by strong performance in its Pattern Generators and Global Technologies divisions. Despite this, net sales declined by 4% due to lower sales in Pattern Generators, impacting the EBIT margin, which fell to 15%. The company is expanding its capabilities with the acquisition of Cowin DST in South Korea, pending regulatory approval, and has relocated PCB Assembly Solutions production to enhance capacity. The US market for PCB Assembly Solutions improved, while demand from the Chinese consumer electronics industry weakened. The Global Technologies division saw strong demand in AI data center markets and aerospace & defense spending in the US.

The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK218.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.

Mycronic Secures Order for SLX Mask Writer in the US

Mycronic AB has secured an order for its SLX mask writer from an existing customer in the US, valued between USD 4-6 million, with delivery expected this quarter. The SLX mask writer addresses the growing demand for photomasks in the semiconductor industry, offering modern, energy-efficient technology that enhances performance and reliability, thus reinforcing Mycronic’s position in the market.

The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK237.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.

Mycronic Secures Order for SLX Mask Writer

Mycronic AB has secured an order for an SLX mask writer from an existing Asian customer, valued between USD 5-7 million, with delivery expected in the second quarter of 2026. This order highlights the growing demand for photomasks in the semiconductor industry and strengthens Mycronic’s market presence, as the SLX mask writer supports modernization and replacement needs with its energy-efficient technology.

The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK237.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.

Mycronic Secures Order for SLX Mask Writer in Asia

Mycronic AB has secured an order for an SLX mask writer from an existing customer in Asia, valued between USD 3-5 million. This order highlights the growing demand for photomasks in the semiconductor industry, with the SLX mask writer offering modern, energy-efficient technology. The successful completion of a qualification project at the customer’s site facilitated the transfer of ownership, underscoring Mycronic’s strong positioning in the market for semiconductor manufacturing equipment.

The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK237.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.

Mycronic Secures Major Order for Mask Writers in Asia

Mycronic AB has secured a significant order for three mask writers from an existing customer in Asia, valued between USD 48-52 million. The order includes one Prexision 8 Evo and two Prexision Lite 8 Evo mask writers, with deliveries scheduled from the second quarter of 2026 to the first quarter of 2027. This order highlights Mycronic’s strong position in the market for display photomasks and its ability to offer tailored solutions that meet both current and future customer needs.

The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK237.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.

Mycronic AB Appoints 2026 Nomination Committee

Mycronic AB has appointed its Nomination Committee for the 2026 Annual General Meeting, following the guidelines set by the 2025 meeting. The committee, representing 39.1% of votes and shares, invites shareholders to submit proposals for consideration ahead of the meeting, indicating a structured approach to stakeholder engagement.

The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK237.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.